- Home
- AVA vs PTGX Comparison
AVA vs PTGX Comparison
Compare AVA & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVA
- PTGX
- Stock Information
- Founded
- AVA 1889
- PTGX 2006
- Country
- AVA United States
- PTGX United States
- Employees
- AVA N/A
- PTGX N/A
- Industry
- AVA Power Generation
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- AVA Utilities
- PTGX Health Care
- Exchange
- AVA Nasdaq
- PTGX Nasdaq
- Market Cap
- AVA 3.1B
- PTGX 3.3B
- IPO Year
- AVA N/A
- PTGX 2016
- Fundamental
- Price
- AVA $37.63
- PTGX $55.32
- Analyst Decision
- AVA Sell
- PTGX Strong Buy
- Analyst Count
- AVA 2
- PTGX 9
- Target Price
- AVA $38.00
- PTGX $67.11
- AVG Volume (30 Days)
- AVA 679.5K
- PTGX 900.6K
- Earning Date
- AVA 08-06-2025
- PTGX 08-05-2025
- Dividend Yield
- AVA 5.21%
- PTGX N/A
- EPS Growth
- AVA N/A
- PTGX N/A
- EPS
- AVA 2.37
- PTGX 0.86
- Revenue
- AVA $1,946,000,000.00
- PTGX $207,801,000.00
- Revenue This Year
- AVA N/A
- PTGX N/A
- Revenue Next Year
- AVA $3.94
- PTGX $53.09
- P/E Ratio
- AVA $15.88
- PTGX $63.65
- Revenue Growth
- AVA 3.16
- PTGX N/A
- 52 Week Low
- AVA $34.80
- PTGX $32.50
- 52 Week High
- AVA $43.09
- PTGX $60.60
- Technical
- Relative Strength Index (RSI)
- AVA 46.74
- PTGX 61.17
- Support Level
- AVA $37.84
- PTGX $49.38
- Resistance Level
- AVA $38.40
- PTGX $51.51
- Average True Range (ATR)
- AVA 0.54
- PTGX 2.02
- MACD
- AVA 0.05
- PTGX 0.02
- Stochastic Oscillator
- AVA 38.64
- PTGX 75.62
About AVA Avista Corporation
Avista Corp is an electric and natural gas utility company. The company has two business segments including Avista Utilities, which provides electric distribution and transmission, and natural gas distribution services in parts of eastern Washington and northern Idaho, and also provides natural gas distribution service in parts of northeastern and southwestern Oregon. Avista Utilities has electric generating facilities in Washington, Idaho, Oregon, and Montana. AEL&P is a regulated utility providing electric services in Juneau, Alaska that is a wholly-owned subsidiary and the primary operating subsidiary of AERC.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.